Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1922 1
1952 1
1955 1
1959 1
1962 2
1963 5
1964 3
1965 8
1966 4
1967 2
1968 5
1969 7
1970 2
1971 6
1972 1
1973 1
1974 5
1975 5
1976 1
1977 2
1978 2
1979 1
1980 5
1981 1
1982 4
1983 8
1984 9
1986 2
1987 2
1989 1
1990 4
1991 2
1992 1
1993 2
1994 2
1995 6
1996 5
1997 3
1998 4
1999 6
2000 6
2001 3
2002 7
2003 4
2004 4
2005 6
2007 2
2008 6
2009 4
2010 5
2011 3
2012 4
2013 3
2014 3
2015 4
2016 5
2017 9
2018 10
2019 4
2020 6
2021 6
2022 4
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

240 results

Results by year

Filters applied: . Clear all
Page 1
104-week efficacy and safety of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease: a phase III open-label extension study (ATB200-07).
Schoser B, Kishnani PS, Bratkovic D, Byrne BJ, Claeys KG, Díaz-Manera J, Laforêt P, Roberts M, Toscano A, van der Ploeg AT, Castelli J, Goldman M, Holdbrook F, Sitaraman Das S, Wasfi Y, Mozaffar T; ATB200-07 Study Group. Schoser B, et al. J Neurol. 2024 May;271(5):2810-2823. doi: 10.1007/s00415-024-12236-0. Epub 2024 Feb 28. J Neurol. 2024. PMID: 38418563 Free PMC article. Clinical Trial.
The MOG antibody non-P42 epitope is predictive of a relapsing course in MOG antibody-associated disease.
Liyanage G, Trewin BP, Lopez JA, Andersen J, Tea F, Merheb V, Nguyen K, Lee FXZ, Fabis-Pedrini MJ, Zou A, Buckland A, Fok A, Barnett MH, Reddel SW, Marignier R, El Hajj A, Monif M, van der Walt A, Lechner-Scott J, Kermode AG, Kalincik T, Broadley SA, Dale RC, Ramanathan S, Brilot F; on behalf the Australasian MOGAD Study Group. Liyanage G, et al. J Neurol Neurosurg Psychiatry. 2024 Jan 30:jnnp-2023-332851. doi: 10.1136/jnnp-2023-332851. Online ahead of print. J Neurol Neurosurg Psychiatry. 2024. PMID: 38290838 Free article.
Generic versus disease-specific adverse event reporting: a comparison of the NSQIP and SAVES databases for the identification of acute care adverse events in adult spine surgery.
Moskven E, Daly CD, Nevin J, Bourassa-Moreau É, Ailon T, Charest-Morin R, Dea N, Dvorak MF, Fisher CG, Kwon BK, Paquette S, Street JT. Moskven E, et al. Among authors: nevin j. J Neurosurg Spine. 2023 Apr 28;39(2):263-270. doi: 10.3171/2023.3.SPINE221437. Print 2023 Aug 1. J Neurosurg Spine. 2023. PMID: 37119107
Tissue-specific modifier alleles determine Mertk loss-of-function traits.
Akalu YT, Mercau ME, Ansems M, Hughes LD, Nevin J, Alberto EJ, Liu XN, He LZ, Alvarado D, Keler T, Kong Y, Philbrick WM, Bosenberg M, Finnemann SC, Iavarone A, Lasorella A, Rothlin CV, Ghosh S. Akalu YT, et al. Among authors: nevin j. Elife. 2022 Aug 15;11:e80530. doi: 10.7554/eLife.80530. Elife. 2022. PMID: 35969037 Free PMC article.
The Science of Handcycling: A Narrative Review.
Nevin J, Kouwijzer I, Stone B, Quittmann OJ, Hettinga F, Abel T, Smith PM. Nevin J, et al. Int J Sports Physiol Perform. 2022 Mar 1;17(3):335-342. doi: 10.1123/ijspp.2021-0458. Epub 2022 Feb 7. Int J Sports Physiol Perform. 2022. PMID: 35130511 Free article. Review.
240 results